Discover how the synergy between AI and cell-free systems is driving a new era in biopharma innovation, accelerating drug ...

One common form of leukemia is acute myeloid leukemia (AML), characterized by a degradation of early blood cell precursors ... new therapeutic approaches. One approach is immunotherapies, such ...

Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc.today announced that they successfully applied Sutro’ ...